For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231016:nRSP2067Qa&default-theme=true
RNS Number : 2067Q JSC Kaspi.kz 16 October 2023
WEEKLY ANNOUNCEMENT
16 October 2023
TRANSACTIONS IN OWN SECURITIES
Kaspi.kz JSC (the "Company") announces that it has purchased the following
number of its global depositary receipts representing common shares on the
London Stock Exchange and on BATS, Chi-X and Turquoise from J.P. Morgan
Securities plc ("JPMS"). Such purchase was effected pursuant to the buyback
programme of the Company as announced on 26 July 2023.
An aggregated breakdown of the trades made by JPMS as part of the buyback
programme is detailed below:
Aggregated transactions:
Days of the transaction Total number of GDRs purchased Daily weighted average purchase price of the GDRs (USD) Exchange Gross Considerations (USD)
09/10/2023 2 660 93,9409 XLON 249 882,79
09/10/2023 3 100 93,9581 BATE 291 270,11
10/10/2023 2 070 94,4757 XLON 195 564,70
10/10/2023 2 280 94,5152 BATE 215 494,66
11/10/2023 2 600 93,6558 XLON 243 505,08
11/10/2023 3 000 93,6492 BATE 280 947,60
12/10/2023 2 600 94,0826 XLON 244 614,76
12/10/2023 3 100 93,9383 BATE 291 208,73
13/10/2023 2 512 92,1184 XLON 231 401,42
13/10/2023 2 983 91,9087 BATE 274 163,65
Sum: 26 905 93,5905 2 518 053,50
A full breakdown of the individual trades made by JPMS as part of the buyback
programme is available through the link
below: http://www.rns-pdf.londonstockexchange.com/rns/2067Q_1-2023-10-16.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/2067Q_1-2023-10-16.pdf)
This announcement does not constitute, or form part of, an offer or any
solicitation of an offer for securities in any jurisdiction.
LEI number 2549003YU6FARG8OAZ13
For further information david.ferguson@kaspi.kz +44 7427 751 275
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSNKABBPBDKQKD